Prescribing trends and indications of antipsychotic medication in Hong Kong from 2004 to 2014: General and vulnerable patient groups

Author:

Lao Kim S.J.1ORCID,Tam Anthony W.Y.1,Wong Ian C.K.12,Besag Frank M.C.234,Man Kenneth K.C.156,Chui Celine S.L.17,Chan Esther W.1ORCID

Affiliation:

1. Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy; The University of Hong Kong; Hong Kong China

2. Research Department of Practice and Policy; UCL School of Pharmacy; London UK

3. East London NHS Foundation Trust; Bedfordshire London UK

4. Institute of Psychiatry; Psychology and Neuroscience; London UK

5. Department of Paediatrics and Adolescent Medicine; The University of Hong Kong; Hong Kong China

6. Department of Medical Informatics; Erasmus University Medical Centre; Rotterdam The Netherlands

7. School of Public health; The University of Hong Kong; Hong Kong China

Funder

Research Grants Council, Hong Kong

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Reference45 articles.

1. National Institute for Health and Care Excellence (NICE) Depression in adults: recognition and management 2016

2. Food and Drug Administration US FDA ALERT [6/16/2008]: FDA is notifying healthcare professionals that both conventional and atypical antipsychotics are associated with an increased risk of mortality in elderly patients treated for dementia-related psychosis. Secondary FDA ALERT [6/16/2008] 2008 http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm124830.htm

3. Antipsychotic drug use and mortality in older adults with dementia;Gill;Ann Intern Med,2007

4. Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly patients;Schneeweiss;CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne,2007

5. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials;Schneider;JAMA,2005

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3